Risk factors
Beyond Air (XAIR) risk factors
Item 1A of every Beyond Air, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2026 10-K risk factors69 risks3 new5 reworded
New risks emphasize commercialization execution, cybersecurity and software-enabled hospital systems, and supplier concentration for LungFit PH.
Filed Jun 26, 2026 - FY2025 10-K risk factors66 risks
Beyond Air relies heavily on the commercial success of its single FDA-approved product, LungFit PH, and its pipeline candidates. The company faces ongoing capital requirements, reliance on third-party manufacturers, and strict regulatory compliance standards.
Filed Jun 20, 2025